US20180271752A1 - Drug delivery capsules with external intelligence - Google Patents

Drug delivery capsules with external intelligence Download PDF

Info

Publication number
US20180271752A1
US20180271752A1 US15/887,371 US201815887371A US2018271752A1 US 20180271752 A1 US20180271752 A1 US 20180271752A1 US 201815887371 A US201815887371 A US 201815887371A US 2018271752 A1 US2018271752 A1 US 2018271752A1
Authority
US
United States
Prior art keywords
capsule
medicament
user
unit
activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/887,371
Inventor
Ventzeslav Petrov Iordanov
Hans Zou
Christoph Wanke
Klaas Kerkhof
Jeffrey A. Shimizu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stoco10 GmbH
Medimetrics Personalized Drug Delivery BV
Biora Therapeutics Inc
Original Assignee
Stoco10 GmbH
Medimetrics Personalized Drug Delivery BV
Progenity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoco10 GmbH, Medimetrics Personalized Drug Delivery BV, Progenity Inc filed Critical Stoco10 GmbH
Priority to US15/887,371 priority Critical patent/US20180271752A1/en
Assigned to PROGENITY, INC. reassignment PROGENITY, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Stoco 10 GmbH
Assigned to MEDIMETRICS PERSONALIZED DRUG DELIVERY, B.V. reassignment MEDIMETRICS PERSONALIZED DRUG DELIVERY, B.V. NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: KERKHOF, KLAAS, WANKE, CHRISTOPH, ZOU, HANS, IORDANOV, VENTZESLAV PETROV, SHIMIZU, JEFFERY A.
Assigned to Stoco 10 GmbH reassignment Stoco 10 GmbH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MEDIMETRICS PERSONALIZED DRUG DELIVERY, B.V.
Publication of US20180271752A1 publication Critical patent/US20180271752A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0076Medicament distribution means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0481Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers working on a schedule basis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • G06F19/00
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16ZINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00Subject matter not provided for in other main groups of this subclass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0266Operational features for monitoring or limiting apparatus function
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/16Details of sensor housings or probes; Details of structural supports for sensors
    • A61B2562/162Capsule shaped sensor housings, e.g. for swallowing or implantation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/07Endoradiosondes
    • A61B5/073Intestinal transmitters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6861Capsules, e.g. for swallowing or implanting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00General characteristics or adaptations
    • A61J2200/70Device provided with specific sensor or indicating means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0418Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with electronic history memory
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0427Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1258Pills, tablets, lozenges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/04Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/04Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • B65D83/0409Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills the dispensing means being adapted for delivering one article, or a single dose, upon each actuation

Definitions

  • This invention relates to the administration of medicaments. More specifically, the invention relates to a smart capsule system for delivery of drugs or other materials to a user.
  • Drug dispensing apparatus and methods have been proposed in which a drug is contained in an enclosed ingestible or insertable capsule. An actuator and controls are also disposed in the capsule, to dispense the drug from the capsule at some specified time or upon a specified event.
  • engineered capsules with mechanical or electronic dispensing and sensing components have been proposed and studied that may be effective at releasing a drug or other medicament at a specified position along the alimentary canal.
  • These controlled released capsules have been proposed in many number of ways, but all are similar in that they tend to be quite complex. The complexity results in a very high cost of manufacture and assembly, and uses to date have generally been limited to research and development.
  • the present invention addresses the foregoing needs in the art by providing a medicament delivery system and methods that include a low-cost, controllable capsule, usable in any number of applications, including daily, generally low cost drug delivery.
  • a system for administering a medicament includes a plurality of capsules, a capsule dispenser, and a capsule activator.
  • Each of the capsules includes a reservoir containing a medicament and an outlet in communication with the reservoir through which the medicament exits the capsule.
  • the capsule dispenser releasably contains the ingestible capsules and is adapted to dispense the capsules to a user in accordance with a predetermined schedule.
  • the capsule activator activates the dispensed capsules prior to administration to the user.
  • a method of administering a medicament to a user includes storing a plurality of capsules in a storage unit, dispensing at least one of the capsules from the storage unit to a user, activating the capsules prior to their administration to the user, and releasing the medicament from the reservoir after administration of the capsule to the user.
  • FIG. 1 is a schematic illustration of a medicament administration system according to an embodiment of the invention.
  • FIG. 2 is a section view of a capsule used in the system illustrated in FIG. 1 .
  • FIG. 3 is a schematic plan view of an external unit used in the system illustrated in FIG. 1 .
  • FIG. 4 is a flow chart illustrating a medicament delivery method according to an embodiment of the invention.
  • FIG. 5 is a section view of another embodiment of a capsule used in the system illustrated in FIG. 1 .
  • FIG. 6 is a schematic representation of a trigger illustrated in the capsule of FIG. 5 .
  • FIG. 7 is a schematic representation of the trigger illustrated in the capsule of FIG. 5 .
  • medicament delivery and more particularly to systems and methods for administering a medicament to a patient.
  • medicament is used herein to mean any substance that can be administered to a user via a capsule.
  • Medicaments include, but are not limited to, pharmaceutically active compounds, drugs, dyes, radio-labeled markers, vaccines, physiological markers, and diagnostic agents.
  • the systems and methods of the disclosure are preferably more economical and robust than existing systems employing engineered drug delivery capsules, while still providing the flexibility, reporting functionality and control offered by existing electronic capsules.
  • Preferred embodiments of the present invention generally provide drug delivery capsules with external intelligence.
  • FIG. 1 shows a first embodiment of the invention, including a medicament delivery system 10 having an electronic capsule 20 and an external device 50 .
  • the external device 50 is so termed only because, unlike the capsule 20 , it is not intended for administration to the user, 10 e.g., by ingestion or insertion.
  • the many features and functionalities of the capsule 20 and the device 50 will be described in more detail, as follows.
  • the capsule 20 is sized for ingestion by or insertion into a user. It preferably includes a reservoir 22 for storing a medicament (not shown) to be administered to the user, an outlet 24 through which the medicament is dispensed from the reservoir 22 , an actuator 26 for aiding in dispensing of the medicament, and controls 28 .
  • the reservoir is initially closed, and in some embodiments sealed, such as by a cap 25 covering the outlet 24 to separate the medicament from the environment.
  • additional features and components may be included in the capsule, but their inclusion may operate to increase the cost of the capsule.
  • the cost of the capsule is kept as low as possible, as the capsule 20 is the disposable piece in the system 10 and keeping the cost of the capsule down will enable the system to be used in a broader range of medicament dispensing applications.
  • the reservoir 22 and outlet 24 preferably are arranged in a conventional manner, with the actuator 26 applying pressure on the contents of the reservoir 22 to cause the medicament to dispense through the outlet 24 . More specifically, as the medicament is pressed by the actuator against the cap 25 , the cap 25 is subjected to a force sufficient to expel the cap 25 from the capsule 20 , thus allowing medicament to exit through the outlet 24 .
  • the controls 28 may take many forms and be of varying complexity, but preferably are arranged to control the actuator to dispense the medicament.
  • the controls 28 may include a power source, such as a battery, an induction coil, or a capacitor, a receiver for receiving instructions to control the actuator to dispense the medicament, and a transmitter for transmitting information, such as an indication that a medicament has been delivered or information about a condition of the capsule.
  • a power source such as a battery, an induction coil, or a capacitor
  • a receiver for receiving instructions to control the actuator to dispense the medicament
  • a transmitter for transmitting information, such as an indication that a medicament has been delivered or information about a condition of the capsule.
  • the capsule may also include any number and manner of sensors (not shown).
  • the capsule may have sensors that detect environmental conditions, such as moisture, pH, and temperature.
  • environmental sensors may be active in that they continuously report on the condition they are designed to monitor, but more preferably they are designed as “binary” sensors that change state upon some condition change.
  • the sensor may include a polymer that erodes in the presence of a specific condition, such as an elevated pH. This erosion causes a detectable short circuit, which detection may be used to turn on the electronics in the capsule. Using this type of sensor will conserve energy over the active sensors mentioned above.
  • Sensors may also be included in or on the capsule, which confirm that the medicament is present in and/or has been discharged from the capsule.
  • the reservoir 22 is defined by a sidewall 21 of the capsule 20 , the cap 25 , and a movable plunger 32 .
  • the outlet 24 is an open end of the capsule 20 .
  • the reservoir may be a bladder or lining disposed in the capsule.
  • the outlet 24 may be a smaller aperture or a plurality of apertures.
  • the outlet 24 may open through the sidewall 21 in addition to or instead of through the capsule 20 .
  • the actuator 26 includes a spring 30 (shown coiled in FIG. 2 ), the plunger 32 , and a filament 34 .
  • the spring 30 Before dispensing the medicament from the capsule 20 , the spring 30 is retained in a retracted position, which is the position illustrated in solid lines in FIG. 2 .
  • the plunger 32 is disposed contacting the spring 30 , between the spring 30 and the reservoir 22 .
  • the filament 34 is fixed to the plunger 32 and to the body of the capsule 20 . According to this arrangement, the filament 34 fixes the position of the plunger 32 longitudinally along the capsule 20 , and the plunger 32 acts against the force of the spring 30 to retain the spring in the compressed position.
  • a heating element 36 also is provided in the capsule of FIG. 2 , proximate the filament 34 .
  • the filament 34 is a meltable filament that melts after being warmed by the heating element for a sufficient time and at a sufficient temperature. Without the connection provided by the filament 34 , the plunger 32 can no longer retain the spring 30 in the compressed position, so the spring extends, driving the plunger 32 to an extended position (not shown in FIG. 2 ).
  • the actuated plunger has sufficient force to press the medicament in the reservoir 22 against the cap 25 to expel the cap 25 , thereby expressing the medicament through the outlet 24 .
  • the heating element 36 may be any conventional heater, although a preferred heating element is a resistive heater that is incorporated into the controls disposed in the capsule.
  • the heater is preferably powered by an on-board power supply, which is also incorporated into the controls.
  • the filament could be broken by means other than melting.
  • the filament could be broken such as by cutting, dissolving, chemical reaction, or any other means.
  • the invention is not limited to the illustrated filament. Any latch or stop capable of retaining the spring in the compressed position and which can subsequently be moved, removed, or destroyed to release the spring may be used.
  • FIG. 5 a capsule substantially the same as the one illustrated in FIG. 2 is provided. Different from FIG. 2 , however, is that FIG. 5 also schematically illustrates a switch 40 .
  • the switch 40 is provided to turn on the heater 36 . In its simplest form, the switch completes a circuit to allow power to the heater 36 .
  • FIGS. 6 and 7 illustrate two embodiments of the switch 40 .
  • Each includes a flexible electrode 42 and a stationary electrode 44 .
  • a circuit is completed to provide power to, and thus turn on, the heater 36 .
  • a dissolvable material 43 is provided between the flexible electrode 42 and the stationary electrode 44 to bias the flexible electrode 42 away from the stationary electrode.
  • the material 43 is chosen to interact with a specific environmental condition within the body, e.g., a fluid of a specific pH. This interaction melts the material, and the flexible electrode 42 returns to an unbiased position, contacting the stationary electrode 44 .
  • an expandable material 45 is provided between a wall 21 of the capsule and the flexible electrode 42 .
  • the flexible electrode 42 is biased toward the stationary electrode 44 , eventually resulting in contact of the two.
  • the capsule described herein is but one example of a relatively low-cost capsule effective to dispense a medicament at a desired time.
  • Other capsules may also be used in the system of this disclosure, without departing from the disclosure's spirit and scope.
  • the capsule may not include a spring at all, but instead the cap or a similar covering is dissolved in a predetermined environment. Once the covering is dissolved, the medicament is unrestrained and diffuses or otherwise exits the capsule.
  • an actuator such as a compressed spring opens a valve allowing fluid from the environment to rush into the capsule. As a result of that rush, a secondary, more powerful actuator is actuated to force the medicament out of the capsule.
  • the actuator may include a gas-forming or osmotic pressure engine that acts to push the medicament from the capsule.
  • a timer may instead be used to trigger an activation of the heater.
  • the capsule 20 is used as part of a medicament dispensing system 10 , which also includes the external device 50 .
  • the capsule 20 is simple in construction and operation, and thus lower in cost, but the system 10 is very comprehensive.
  • the external device 50 is configured to accomplish much of the functionality of the system, other than actual dispensing.
  • the external device 50 includes a receptacle 52 that is sized and configured to store a plurality of the capsules 20 .
  • the capsules 20 may be provided in a unique package, such as a cartridge, for ready insertion into the receptacle 52 , but the manner of retaining the capsules 20 in the receptacle is not limited.
  • the external device 50 also includes an access opening 54 through which the user accesses the capsules 20 stored in the external device 50 .
  • the access opening preferably allows the user access to less than all of the capsules 20 , and more preferably allows access only to the capsule or capsules that are to be administered at a given time.
  • the external device 50 also acts as a dispenser of the capsules 20 , similar to a conventional vending machine.
  • suitable mechanical and electronic components may be included and/or required to achieve this dispensing feature.
  • Such features may be similar to those found in conventional pill dispensing features, such as the PHILIPS@ Medication Dispensing Service.
  • the external device 50 preferably also includes a capsule activator 56 .
  • the capsule activator 56 renders each capsule capable of dispensing medicament. That is, at the time of insertion into the external device 50 , each capsule contains an amount of medicament, but is passive and thus unable to dispense the medicament. Put another way, the passive capsule locks the medicament inside and will not normally dispense the medicament until it is unlocked. Thus, upon being placed in the receptacle 52 , the capsule is in a passive, nondispensed state. The capsule activator 56 changes the capsule to an active, non-dispensed state.
  • the capsule activator is a charger that charges a power source on the capsule.
  • the capsule activator may inductively charge an induction coil or induction bank or charge a capacitor contained in the capsule.
  • the capsule activator may “wake up” or “power on” the capsule's power supply and/or electronics, such as by activating a switch on the capsule.
  • the capsule activator charges the actuator, such as by pre-loading a spring.
  • Other means of activating the capsules may also be contemplated.
  • the activation feature of this disclosure has other benefits, as well. For example, if a user takes a capsule that is not activated, it will not dispense its contents, because those contents are locked inside. Controlled activation will prevent accidental overdoses, and could help curb narcotic abuse.
  • the capsule activator 56 is integrated with the dispensing function of the external unit.
  • the capsule activator 56 is arranged proximate the access opening 54 such that the capsule is activated at the time the capsule is accessible to the user.
  • the capsule activator may be provided in the form of a port or cradle into which a to-be-dispensed pill is placed for activation, and this port or cradle can be arranged at the access opening 54 .
  • the activation port is upstream of the access opening 54 .
  • an activation port serving as the capsule activator 56 may be inside the external device 50 where it activates the capsule prior to the pill being presented to the user at the access opening 54 .
  • the capsule activator 56 may operate separately from the dispensing function. For example, a capsule may be dispensed to a user via the access opening 54 , at which time the user places the capsule in the capsule activator 56 .
  • visual, audible, or other indicia may be provided in connection with the capsule activator 56 , to alert the user that the capsule is activated.
  • the external unit 50 allows for controlled dispensing and activation of capsules.
  • the external unit 50 preferably includes a programmable memory 58 for storing a medicament administration profile.
  • This profile provides the schedule that dictates when the capsules are to be activated and/or dispensed.
  • the profile may be determined based on the drug, characteristics of the user, or some combination of the two.
  • the medicament administration profile is uploaded to the external unit, e.g., by a computer interface, the user, the medicament administrator, the prescribing doctor, a pharmacist, or the drug manufacturer/packager.
  • the profile may be updated as prescriptions or conditions change.
  • the dispenser may be pre-programmed with the administration profile, and unchangeable by the user.
  • the external unit preferably also includes a clock 60 .
  • Most medicament administration profiles include a frequency of drug administration.
  • the clock 60 is used to time dispensing and/or activation based on the administration profiles.
  • the clock also may be used to establish a release time for the medicament.
  • the clock 60 may be used to determine an elapsed time after activation or after ingestion, which elapsed time could be predetermined and used to instruct release of the medicament from the activated capsule, for example by activating the heater of the capsule of FIG. 2 .
  • the external unit 50 may also include a receiver 62 and a transmitter 64 .
  • the receiver 62 may be of any conventional arrangement, including but not limited a wired or a wireless receiver.
  • the receiver is configured to receive the medicament administration profile.
  • the receiver also may receive information from an activated capsule, including but not limited to, information relating to a position of the capsule, confirmation that the capsule has dispensed its medicament, and information that the capsule has been ingested. Information received by the receiver may be stored by the external unit 50 , such as in memory (not shown).
  • the transmitter 64 may be used to transmit instructions to an activated capsule to release the stored medicament.
  • the transmitter 64 also may be used to transfer any information stored on the external unit, for example, to a caregiver or technician, such that stored information can be reviewed for diagnostic purposes.
  • the external unit 50 preferably also includes some number of user interfaces and/or user indicators.
  • the external unit 50 includes a light 66 as a visible indicator.
  • the light 66 indicates when a medicament is to be administered.
  • the release profile in conjunction with the clock, determines that a medicament is to be administered, the light 66 will illuminate.
  • Other visual indicators such as digital displays, touch screen displays, and the like, may also or alternatively be used.
  • the indicator is not limited to a visual indicator.
  • An audible alarm may also or alternatively be included in the external unit 50 .
  • a capsule may be dispensed and/or activated when the user receives the indication that the medicament is to be administered, in some embodiments, the user will first acknowledge that the indication has been administered.
  • a dispense button 68 is provided on the external display. The user pushes the dispense button 68 upon receiving an indication that it is time to administer the medicament and the unit dispenses the capsule. As described above, activation may also occur at the time of dispensing.
  • a preferred system includes two components, namely, a capsule and an external unit.
  • the disclosure is not limited to this arrangement.
  • the external unit may consist of more than one component.
  • the capsule has one or more of a transmitter and a receiver
  • the user may be required to remain in close proximity with the external unit, to allow for communication. So the user is not tethered to one location, he may be provided with a wearable module that, among other features, facilitates communication with the capsule.
  • a separate, stationary module would then be provided, to perform other functions of the external unit described above, such as dispensing and activation.
  • the features and functions of the external unit may be parsed among any number of modules, as design dictates.
  • step 110 the external unit determines that it is time to administer a capsule. This is done using information from the aforementioned and described medicament administration profile. This determination will likely also include inputs from the clock or other sources.
  • step 120 the user is alerted to the fact that it is time to administer the medicament.
  • the user is notified when a light on the external unit 50 is turned on.
  • the user could be notified by an audible indicator.
  • the external device could notify the user by sending a message such as a text or email message to a device carried by the user.
  • the capsule is prepared for activation.
  • it may be placed in a port or cradle that will act as or in connection with the capsule activator described above.
  • the capsule is automatically placed, i.e., by a mechanism in the external unit, in to the port or cradle.
  • step 130 may include presenting a passive capsule to the user, who manually transfers the capsule to the capsule activator or who manually activates the capsule, e.g., by activating a switch on the capsule.
  • the capsule is activated.
  • the capsule prior to this step, the capsule is preferably passive or dormant. That is, it will not dispense the medicament absent some unauthorized external force that operably destroys the capsule. Only after the capsule is activated, in this step 140 , will the capsule be prepared to dispense the medicament as intended.
  • the capsule may be activated by being coupled to an energy source, with energy from the source being stored in the capsule for functional operation.
  • the capsule may be plugged in to charge a battery or capacitor stored therein, or the battery or capacitor may be charged inductively.
  • the activation may also be done by changing an electrical or mechanical switch, such as from an “off to an “on” position
  • step 150 the capsule is administered to the user.
  • the user ingests the capsule, but other means of administering the capsule, such as by rectal or vaginal insertion, are also contemplated.
  • the capsule receives information that a triggering event has occurred.
  • the triggering event may be any number of events, including but not limited to activation of the capsule (step 140 ) or administration of the capsule (step 150 ).
  • Administration of the capsule may be detected by including a moisture-detecting sensor on the capsule to determine when the capsule enters the relatively moist environment of the user's alimentary canal. The user may also manually verify that he administered the capsule, such as by pressing a button on the external unit.
  • the capsule may include a pH sensor, and detection of a certain, predetermined pH value will be the triggering event.
  • step 170 the capsule dispenses the medicament such as by opening the capsule's reservoir, as discussed above. Dispensing may occur immediately upon the triggering event or it may happen at some predetermined time after the triggering event.
  • the capsule reports that the medicament has been dispensed. It may do this by sending a signal, e.g., by RF transmission, to the external unit.
  • a state of the capsule may be changed when the medicament is released, and the user may note this change in state when the capsule is passed.
  • the indication that the medicament has been dispensed may be a binary indication, or it may be more in depth, depending upon the sensing capabilities of the capsule and the external unit.
  • the indication that the medicament has been dispensed may include a location of dispensing, a time of dispensing, and/or any other pertinent information. This step 180 may not be required at all in some embodiments, for example, if there is sufficient confidence that an administered capsule will function properly.
  • the external unit starts a timer that will establish when the next administration of the medicament is to take place.
  • the timer may be started when administration of the medicament is determined, in step 180 . In other embodiments, the timer may be started when a capsule is dispensed, when a capsule is activated, when a capsule is ingested, or upon the triggering event occurring in step 170 .
  • each of the steps is preferably stored in a memory of the external unit, thus allowing a user or caregiver the ability to track and confirm administration of the medicament. This knowledge is particularly valuable when coupled with other information about the user, because it allows for accurate diagnosis and indication of treatment regiments.
  • the capsule may include a memory storing the administration schedule, such that it need not receive instruction from the external unit to dispense the medicament.
  • a small processor may be provided in each capsule, such that the capsule detects the triggering event and as a direct result of the triggering event, or after some elapsed time calculated by a clock in the capsule, releases the medicament.

Abstract

A system for administering a medicament includes a plurality of capsules, a capsule dispenser, and a capsule activator. Each of the capsules includes a reservoir containing a medicament and an outlet in communication with the reservoir through which the medicament exits the capsule. The capsule dispenser releasably contains the ingestible capsules and is adapted to dispense the capsules to a user in accordance with a predetermined schedule. The capsule activator activates the dispensed capsules prior to administration to the user.

Description

    CROSS REFERENCE TO RELATED APPLICATION
  • This Application is Continuation of U.S. patent application Ser. No. 14/434,548 filed Apr. 9, 2015, which was a 35 U.S.C. 371 National Stage Entry Application of and claiming priority to PCT Application No. PCT/US2013/061202 entitled “Drug Delivery Capsules With External Intelligence” filed on Sep. 23, 2013, which claims priority to U.S. Provisional Patent Application No. 61/711,627 filed on Oct. 9, 2012, entitled “Drug Delivery Capsules With External Intelligence,” both of which are hereby incorporated by reference in their entirety.
  • BACKGROUND OF THE INVENTION TECHNICAL FIELD
  • This invention relates to the administration of medicaments. More specifically, the invention relates to a smart capsule system for delivery of drugs or other materials to a user.
  • DESCRIPTION OF RELATED ART
  • Drug dispensing apparatus and methods have been proposed in which a drug is contained in an enclosed ingestible or insertable capsule. An actuator and controls are also disposed in the capsule, to dispense the drug from the capsule at some specified time or upon a specified event. To date, engineered capsules with mechanical or electronic dispensing and sensing components have been proposed and studied that may be effective at releasing a drug or other medicament at a specified position along the alimentary canal. These controlled released capsules have been proposed in many number of ways, but all are similar in that they tend to be quite complex. The complexity results in a very high cost of manufacture and assembly, and uses to date have generally been limited to research and development. However, the controlled release of these capsules would be extremely beneficial in everyday usage for treating maladies of the alimentary canal, or even more broadly for dispensing any type of medication within a body cavity, such as at a desired position along the alimentary canal. However, as noted above, the cost associated with the complexity makes this impractical.
  • Accordingly, there is a need in the art for a low cost electronic capsule that could be used to dispense drugs intended to be taken at some determined time or interval.
  • Another drawback associated with conventional drug delivery systems, is that the user may administer as many doses as he desires, and in whatever interval they see fit. This is true even if the self-administered dosaging does not comport with recommended amounts. This can lead to ineffective treatment, and in some extreme examples, overdosing or unintended dependency.
  • Thus, there also is a need in the art for a medicament delivery system in which dosing of drugs is recorded and allowed only at specific times.
  • SUMMARY OF THE INVENTION
  • The present invention addresses the foregoing needs in the art by providing a medicament delivery system and methods that include a low-cost, controllable capsule, usable in any number of applications, including daily, generally low cost drug delivery.
  • In one aspect of the invention, a system for administering a medicament includes a plurality of capsules, a capsule dispenser, and a capsule activator. Each of the capsules includes a reservoir containing a medicament and an outlet in communication with the reservoir through which the medicament exits the capsule. The capsule dispenser releasably contains the ingestible capsules and is adapted to dispense the capsules to a user in accordance with a predetermined schedule. The capsule activator activates the dispensed capsules prior to administration to the user.
  • In another aspect of the invention, a method of administering a medicament to a user includes storing a plurality of capsules in a storage unit, dispensing at least one of the capsules from the storage unit to a user, activating the capsules prior to their administration to the user, and releasing the medicament from the reservoir after administration of the capsule to the user.
  • These and other features, aspects and embodiments of the invention will be better understood with reference to the appended drawing figures and following detailed description of the invention in which preferred embodiments of the invention are shown and described.
  • BRIEF DESCRIPTION OF THE DRAWING FIGURES
  • FIG. 1 is a schematic illustration of a medicament administration system according to an embodiment of the invention.
  • FIG. 2 is a section view of a capsule used in the system illustrated in FIG. 1.
  • FIG. 3 is a schematic plan view of an external unit used in the system illustrated in FIG. 1.
  • FIG. 4 is a flow chart illustrating a medicament delivery method according to an embodiment of the invention.
  • FIG. 5 is a section view of another embodiment of a capsule used in the system illustrated in FIG. 1.
  • FIG. 6 is a schematic representation of a trigger illustrated in the capsule of FIG. 5.
  • FIG. 7 is a schematic representation of the trigger illustrated in the capsule of FIG. 5.
  • DETAILED DESCRIPTION OF THE INVENTION
  • As noted above, the present disclosure relates to medicament delivery and more particularly to systems and methods for administering a medicament to a patient. The term medicament is used herein to mean any substance that can be administered to a user via a capsule. Medicaments include, but are not limited to, pharmaceutically active compounds, drugs, dyes, radio-labeled markers, vaccines, physiological markers, and diagnostic agents.
  • The systems and methods of the disclosure are preferably more economical and robust than existing systems employing engineered drug delivery capsules, while still providing the flexibility, reporting functionality and control offered by existing electronic capsules. Preferred embodiments of the present invention generally provide drug delivery capsules with external intelligence.
  • FIG. 1 shows a first embodiment of the invention, including a medicament delivery system 10 having an electronic capsule 20 and an external device 50. The external device 50 is so termed only because, unlike the capsule 20, it is not intended for administration to the user, 10 e.g., by ingestion or insertion. The many features and functionalities of the capsule 20 and the device 50 will be described in more detail, as follows.
  • An embodiment of the capsule 20 is illustrated in FIG. 2. The capsule 20 is sized for ingestion by or insertion into a user. It preferably includes a reservoir 22 for storing a medicament (not shown) to be administered to the user, an outlet 24 through which the medicament is dispensed from the reservoir 22, an actuator 26 for aiding in dispensing of the medicament, and controls 28. The reservoir is initially closed, and in some embodiments sealed, such as by a cap 25 covering the outlet 24 to separate the medicament from the environment. In alternative embodiments, some of which will be discussed below, additional features and components may be included in the capsule, but their inclusion may operate to increase the cost of the capsule. As noted above, in some embodiments of the invention the cost of the capsule is kept as low as possible, as the capsule 20 is the disposable piece in the system 10 and keeping the cost of the capsule down will enable the system to be used in a broader range of medicament dispensing applications.
  • The reservoir 22 and outlet 24 preferably are arranged in a conventional manner, with the actuator 26 applying pressure on the contents of the reservoir 22 to cause the medicament to dispense through the outlet 24. More specifically, as the medicament is pressed by the actuator against the cap 25, the cap 25 is subjected to a force sufficient to expel the cap 25 from the capsule 20, thus allowing medicament to exit through the outlet 24. The controls 28 may take many forms and be of varying complexity, but preferably are arranged to control the actuator to dispense the medicament. In their various forms, some of which will be described in more detail below, the controls 28 may include a power source, such as a battery, an induction coil, or a capacitor, a receiver for receiving instructions to control the actuator to dispense the medicament, and a transmitter for transmitting information, such as an indication that a medicament has been delivered or information about a condition of the capsule.
  • The capsule may also include any number and manner of sensors (not shown). For example, the capsule may have sensors that detect environmental conditions, such as moisture, pH, and temperature. Such environmental sensors may be active in that they continuously report on the condition they are designed to monitor, but more preferably they are designed as “binary” sensors that change state upon some condition change. For example, the sensor may include a polymer that erodes in the presence of a specific condition, such as an elevated pH. This erosion causes a detectable short circuit, which detection may be used to turn on the electronics in the capsule. Using this type of sensor will conserve energy over the active sensors mentioned above. Sensors may also be included in or on the capsule, which confirm that the medicament is present in and/or has been discharged from the capsule.
  • In FIG. 2, the reservoir 22 is defined by a sidewall 21 of the capsule 20, the cap 25, and a movable plunger 32. The outlet 24 is an open end of the capsule 20. In other embodiments, the reservoir may be a bladder or lining disposed in the capsule. Moreover, the outlet 24 may be a smaller aperture or a plurality of apertures. The outlet 24 may open through the sidewall 21 in addition to or instead of through the capsule 20.
  • In this embodiment, the actuator 26 includes a spring 30 (shown coiled in FIG. 2), the plunger 32, and a filament 34. Before dispensing the medicament from the capsule 20, the spring 30 is retained in a retracted position, which is the position illustrated in solid lines in FIG. 2. The plunger 32 is disposed contacting the spring 30, between the spring 30 and the reservoir 22. The filament 34 is fixed to the plunger 32 and to the body of the capsule 20. According to this arrangement, the filament 34 fixes the position of the plunger 32 longitudinally along the capsule 20, and the plunger 32 acts against the force of the spring 30 to retain the spring in the compressed position.
  • A heating element 36 also is provided in the capsule of FIG. 2, proximate the filament 34. The filament 34 is a meltable filament that melts after being warmed by the heating element for a sufficient time and at a sufficient temperature. Without the connection provided by the filament 34, the plunger 32 can no longer retain the spring 30 in the compressed position, so the spring extends, driving the plunger 32 to an extended position (not shown in FIG. 2). The actuated plunger has sufficient force to press the medicament in the reservoir 22 against the cap 25 to expel the cap 25, thereby expressing the medicament through the outlet 24. The heating element 36 may be any conventional heater, although a preferred heating element is a resistive heater that is incorporated into the controls disposed in the capsule. The heater is preferably powered by an on-board power supply, which is also incorporated into the controls. In other embodiments, the filament could be broken by means other than melting. For example, the filament could be broken such as by cutting, dissolving, chemical reaction, or any other means. The invention is not limited to the illustrated filament. Any latch or stop capable of retaining the spring in the compressed position and which can subsequently be moved, removed, or destroyed to release the spring may be used.
  • In FIG. 5, a capsule substantially the same as the one illustrated in FIG. 2 is provided. Different from FIG. 2, however, is that FIG. 5 also schematically illustrates a switch 40. The switch 40 is provided to turn on the heater 36. In its simplest form, the switch completes a circuit to allow power to the heater 36.
  • FIGS. 6 and 7 illustrate two embodiments of the switch 40. Each includes a flexible electrode 42 and a stationary electrode 44. When the two electrodes come into contact, a circuit is completed to provide power to, and thus turn on, the heater 36.
  • In FIG. 6, a dissolvable material 43 is provided between the flexible electrode 42 and the stationary electrode 44 to bias the flexible electrode 42 away from the stationary electrode. The material 43 is chosen to interact with a specific environmental condition within the body, e.g., a fluid of a specific pH. This interaction melts the material, and the flexible electrode 42 returns to an unbiased position, contacting the stationary electrode 44.
  • In FIG. 7, an expandable material 45 is provided between a wall 21 of the capsule and the flexible electrode 42. As the material 45 expands or swells, e.g., due to absorption of water or some other bodily fluid, the flexible electrode 42 is biased toward the stationary electrode 44, eventually resulting in contact of the two.
  • As will be appreciated by those having ordinary skill in the art, the capsule described herein is but one example of a relatively low-cost capsule effective to dispense a medicament at a desired time. Other capsules may also be used in the system of this disclosure, without departing from the disclosure's spirit and scope. In one alternative example, the capsule may not include a spring at all, but instead the cap or a similar covering is dissolved in a predetermined environment. Once the covering is dissolved, the medicament is unrestrained and diffuses or otherwise exits the capsule. In another embodiment, an actuator such as a compressed spring opens a valve allowing fluid from the environment to rush into the capsule. As a result of that rush, a secondary, more powerful actuator is actuated to force the medicament out of the capsule. In still another embodiment, the actuator may include a gas-forming or osmotic pressure engine that acts to push the medicament from the capsule. Moreover, although a mechanical trigger is illustrated in FIGS. 6 and 7, a timer may instead be used to trigger an activation of the heater.
  • As noted above, the capsule 20 is used as part of a medicament dispensing system 10, which also includes the external device 50. In a preferred embodiment, the capsule 20 is simple in construction and operation, and thus lower in cost, but the system 10 is very comprehensive. Accordingly, the external device 50 is configured to accomplish much of the functionality of the system, other than actual dispensing.
  • As illustrated in the schematic top view of FIG. 3, the external device 50 includes a receptacle 52 that is sized and configured to store a plurality of the capsules 20. The capsules 20 may be provided in a unique package, such as a cartridge, for ready insertion into the receptacle 52, but the manner of retaining the capsules 20 in the receptacle is not limited. The external device 50 also includes an access opening 54 through which the user accesses the capsules 20 stored in the external device 50. The access opening preferably allows the user access to less than all of the capsules 20, and more preferably allows access only to the capsule or capsules that are to be administered at a given time. Thus, the external device 50 also acts as a dispenser of the capsules 20, similar to a conventional vending machine. Although not illustrated, suitable mechanical and electronic components may be included and/or required to achieve this dispensing feature. Such features may be similar to those found in conventional pill dispensing features, such as the PHILIPS@ Medication Dispensing Service.
  • The external device 50 preferably also includes a capsule activator 56. The capsule activator 56 renders each capsule capable of dispensing medicament. That is, at the time of insertion into the external device 50, each capsule contains an amount of medicament, but is passive and thus unable to dispense the medicament. Put another way, the passive capsule locks the medicament inside and will not normally dispense the medicament until it is unlocked. Thus, upon being placed in the receptacle 52, the capsule is in a passive, nondispensed state. The capsule activator 56 changes the capsule to an active, non-dispensed state. In one presently preferred embodiment, the capsule activator is a charger that charges a power source on the capsule. For example, the capsule activator may inductively charge an induction coil or induction bank or charge a capacitor contained in the capsule. In another embodiment, the capsule activator may “wake up” or “power on” the capsule's power supply and/or electronics, such as by activating a switch on the capsule. In still another embodiment, the capsule activator charges the actuator, such as by pre-loading a spring. Other means of activating the capsules may also be contemplated. As will be appreciated, the activation feature of this disclosure has other benefits, as well. For example, if a user takes a capsule that is not activated, it will not dispense its contents, because those contents are locked inside. Controlled activation will prevent accidental overdoses, and could help curb narcotic abuse.
  • In one embodiment, the capsule activator 56 is integrated with the dispensing function of the external unit. For example, the capsule activator 56 is arranged proximate the access opening 54 such that the capsule is activated at the time the capsule is accessible to the user. The capsule activator may be provided in the form of a port or cradle into which a to-be-dispensed pill is placed for activation, and this port or cradle can be arranged at the access opening 54. In another embodiment, the activation port is upstream of the access opening 54. For example, an activation port serving as the capsule activator 56 may be inside the external device 50 where it activates the capsule prior to the pill being presented to the user at the access opening 54.
  • In still another embodiment of the invention, the capsule activator 56 may operate separately from the dispensing function. For example, a capsule may be dispensed to a user via the access opening 54, at which time the user places the capsule in the capsule activator 56. In this embodiment, visual, audible, or other indicia may be provided in connection with the capsule activator 56, to alert the user that the capsule is activated.
  • The external unit 50 allows for controlled dispensing and activation of capsules. To this end, the external unit 50 preferably includes a programmable memory 58 for storing a medicament administration profile. This profile provides the schedule that dictates when the capsules are to be activated and/or dispensed. The profile may be determined based on the drug, characteristics of the user, or some combination of the two. In preferred embodiments, the medicament administration profile is uploaded to the external unit, e.g., by a computer interface, the user, the medicament administrator, the prescribing doctor, a pharmacist, or the drug manufacturer/packager. When an interface is provided, the profile may be updated as prescriptions or conditions change. In other embodiments, the dispenser may be pre-programmed with the administration profile, and unchangeable by the user.
  • The external unit preferably also includes a clock 60. Most medicament administration profiles include a frequency of drug administration. The clock 60 is used to time dispensing and/or activation based on the administration profiles. The clock also may be used to establish a release time for the medicament. For example, the clock 60 may be used to determine an elapsed time after activation or after ingestion, which elapsed time could be predetermined and used to instruct release of the medicament from the activated capsule, for example by activating the heater of the capsule of FIG. 2.
  • The external unit 50 may also include a receiver 62 and a transmitter 64. The receiver 62 may be of any conventional arrangement, including but not limited a wired or a wireless receiver. In one embodiment, the receiver is configured to receive the medicament administration profile. The receiver also may receive information from an activated capsule, including but not limited to, information relating to a position of the capsule, confirmation that the capsule has dispensed its medicament, and information that the capsule has been ingested. Information received by the receiver may be stored by the external unit 50, such as in memory (not shown).
  • The transmitter 64 may be used to transmit instructions to an activated capsule to release the stored medicament. The transmitter 64 also may be used to transfer any information stored on the external unit, for example, to a caregiver or technician, such that stored information can be reviewed for diagnostic purposes.
  • The external unit 50 preferably also includes some number of user interfaces and/or user indicators. In the illustrated embodiment, the external unit 50 includes a light 66 as a visible indicator. The light 66 indicates when a medicament is to be administered. Thus, when the release profile, in conjunction with the clock, determines that a medicament is to be administered, the light 66 will illuminate. Other visual indicators, such as digital displays, touch screen displays, and the like, may also or alternatively be used. Moreover, the indicator is not limited to a visual indicator. An audible alarm may also or alternatively be included in the external unit 50.
  • While the inventors contemplate that a capsule may be dispensed and/or activated when the user receives the indication that the medicament is to be administered, in some embodiments, the user will first acknowledge that the indication has been administered. To this end, a dispense button 68 is provided on the external display. The user pushes the dispense button 68 upon receiving an indication that it is time to administer the medicament and the unit dispenses the capsule. As described above, activation may also occur at the time of dispensing.
  • As just described, a preferred system according to the disclosure includes two components, namely, a capsule and an external unit. The disclosure is not limited to this arrangement. The external unit may consist of more than one component. For instance, when the capsule has one or more of a transmitter and a receiver, the user may be required to remain in close proximity with the external unit, to allow for communication. So the user is not tethered to one location, he may be provided with a wearable module that, among other features, facilitates communication with the capsule. A separate, stationary module would then be provided, to perform other functions of the external unit described above, such as dispensing and activation. The features and functions of the external unit may be parsed among any number of modules, as design dictates.
  • Methods of administering a medicament using the system 10 described above now will be described, with particular reference to the flow chart of FIG. 4.
  • In step 110, the external unit determines that it is time to administer a capsule. This is done using information from the aforementioned and described medicament administration profile. This determination will likely also include inputs from the clock or other sources.
  • In step 120, the user is alerted to the fact that it is time to administer the medicament. In the embodiment discussed above, the user is notified when a light on the external unit 50 is turned on. Alternatively, the user could be notified by an audible indicator. In still other embodiments, the external device could notify the user by sending a message such as a text or email message to a device carried by the user.
  • In step 130, the capsule is prepared for activation. For example, it may be placed in a port or cradle that will act as or in connection with the capsule activator described above. In a preferred embodiment, the capsule is automatically placed, i.e., by a mechanism in the external unit, in to the port or cradle. In other embodiments, step 130 may include presenting a passive capsule to the user, who manually transfers the capsule to the capsule activator or who manually activates the capsule, e.g., by activating a switch on the capsule.
  • In step 140, the capsule is activated. As will be appreciated, prior to this step, the capsule is preferably passive or dormant. That is, it will not dispense the medicament absent some unauthorized external force that operably destroys the capsule. Only after the capsule is activated, in this step 140, will the capsule be prepared to dispense the medicament as intended. In some embodiments the capsule may be activated by being coupled to an energy source, with energy from the source being stored in the capsule for functional operation. For example, the capsule may be plugged in to charge a battery or capacitor stored therein, or the battery or capacitor may be charged inductively. The activation may also be done by changing an electrical or mechanical switch, such as from an “off to an “on” position
  • In step 150, the capsule is administered to the user. In a preferred embodiment the user ingests the capsule, but other means of administering the capsule, such as by rectal or vaginal insertion, are also contemplated.
  • In step 160, the capsule receives information that a triggering event has occurred. The triggering event may be any number of events, including but not limited to activation of the capsule (step 140) or administration of the capsule (step 150). Administration of the capsule may be detected by including a moisture-detecting sensor on the capsule to determine when the capsule enters the relatively moist environment of the user's alimentary canal. The user may also manually verify that he administered the capsule, such as by pressing a button on the external unit. In another embodiment, the capsule may include a pH sensor, and detection of a certain, predetermined pH value will be the triggering event.
  • After detection of the triggering event, in step 170 the capsule dispenses the medicament such as by opening the capsule's reservoir, as discussed above. Dispensing may occur immediately upon the triggering event or it may happen at some predetermined time after the triggering event.
  • In step 11 80, the capsule reports that the medicament has been dispensed. It may do this by sending a signal, e.g., by RF transmission, to the external unit. In other embodiments, a state of the capsule may be changed when the medicament is released, and the user may note this change in state when the capsule is passed. The indication that the medicament has been dispensed may be a binary indication, or it may be more in depth, depending upon the sensing capabilities of the capsule and the external unit. For example, the indication that the medicament has been dispensed may include a location of dispensing, a time of dispensing, and/or any other pertinent information. This step 180 may not be required at all in some embodiments, for example, if there is sufficient confidence that an administered capsule will function properly.
  • In step 190, the external unit starts a timer that will establish when the next administration of the medicament is to take place. The timer may be started when administration of the medicament is determined, in step 180. In other embodiments, the timer may be started when a capsule is dispensed, when a capsule is activated, when a capsule is ingested, or upon the triggering event occurring in step 170.
  • The methods just described, and variations thereof, are effective at accurately administering medicaments to a user according to a predetermined schedule. The improved methods inhibit improper administration of medicaments. Moreover, each of the steps is preferably stored in a memory of the external unit, thus allowing a user or caregiver the ability to track and confirm administration of the medicament. This knowledge is particularly valuable when coupled with other information about the user, because it allows for accurate diagnosis and indication of treatment regiments.
  • Moreover, although presently preferred embodiments of the disclosure have the bulk of the intelligence of the system in the external unit, such is not required. In one alternative embodiment, the capsule may include a memory storing the administration schedule, such that it need not receive instruction from the external unit to dispense the medicament. Similarly, a small processor may be provided in each capsule, such that the capsule detects the triggering event and as a direct result of the triggering event, or after some elapsed time calculated by a clock in the capsule, releases the medicament.
  • The foregoing embodiments of the present invention are provided as exemplary embodiments and are presently best modes for carrying out the invention. Modifications of these embodiments will be readily apparent to those of ordinary skill in the art. The invention is not intended to be limited by the foregoing embodiments, but instead is intended to be limited only by the appended claims.

Claims (22)

1. A system comprising:
a capsule, comprising:
a reservoir configured to contain a medicament;
an outlet; and
an actuator; and
a unit external to the capsule,
wherein the unit comprises an activator configured so that:
in a first state of the system prior activation of the capsule by the activator and prior to administration of the capsule to a user, the capsule is configured to keep the medicament within the reservoir; and
in a second state of the system after activation of the capsule by the activator and prior to administration of the capsule to the user, the activator activates the capsule so that the actuator is capable of expelling the medicament from the capsule via the outlet.
2. The system of claim 1, wherein the capsule further comprises a power source, and the activator is configured to activate the capsule by charging the power source.
3. The system of claim 1, wherein the actuator further comprises a spring, and the activator is configured to activate the capsule by loading the spring.
4. The system of claim 1, wherein the unit further comprises a dispenser configured to house the capsule prior to administration to the user and to dispense the capsule when the capsule is activated.
5. The system of claim 4, wherein the activator is configured to activate the capsule while the capsule is housed in the dispenser.
6. The system of claim 4, wherein dispenser is configured to dispense the capsule according to a predetermined schedule.
7. The system of claim 1, wherein the capsule and the unit are configured to wirelessly communicate with each other.
8. The system of claim 1, wherein the capsule and the unit are configured to wirelessly communicate a medicament administration profile from the unit to the capsule.
9. The system of claim 1, wherein the unit is configured to wirelessly communicate with both the capsule and a member external to the system.
10. The system of claim 9, wherein the member comprises a human other than the user.
11. The system of claim 9, wherein the member comprises an object configured to be worn by the user.
12. The system of claim 1, wherein the unit is configured to wirelessly communicate a medicament administration profile from an external member to the capsule via the unit.
13. The system of claim 12, wherein the member comprises a human other than the user.
14. The system of claim 12, wherein the member comprises an object configured to be worn by the user.
15. The system of claim 1, wherein the unit is configured to wirelessly communicate with a member external to the system.
16. The system of claim 15, wherein the member comprises a human other than the user.
17. The system of claim 15, wherein the member comprises an object configured to be worn by the user.
18. The system of claim 1, wherein the unit and a member external to the system are configured to wirelessly communicate a medicament administration profile from the member to the unit.
19. The system of claim 18, wherein the member comprises a human other than the user.
20. The system of claim 18, wherein the member comprises an object configured to be worn by the user.
21. A system, comprising:
a capsule, comprising:
a reservoir configured to contain a medicament;
an outlet; and
an actuator; and
a unit external to the capsule,
wherein the unit comprises an activator configured so that:
in a first state of the system prior activation of the capsule by the activator and when the capsule is in the unit, the capsule is configured to keep the medicament within the reservoir; and
in a second state of the system after activation of the capsule by the activator and when the capsule is in the unit, the activator activates the capsule so that the actuator is capable of expelling the medicament from the capsule via the outlet.
22. A system, comprising:
a capsule, comprising:
a reservoir configured to contain a medicament;
an outlet through which the medicament may leave the capsule; and
a unit configured to house and dispense the capsule,
wherein at least one of the following holds:
the unit is configured to wirelessly communicate with the capsule; and
the unit is configured to wirelessly communicate with a member external to the system.
US15/887,371 2012-10-09 2018-02-02 Drug delivery capsules with external intelligence Abandoned US20180271752A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/887,371 US20180271752A1 (en) 2012-10-09 2018-02-02 Drug delivery capsules with external intelligence

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261711627P 2012-10-09 2012-10-09
PCT/US2013/061202 WO2014058605A1 (en) 2012-10-09 2013-09-23 Drug delivery capsules with external intelligence
US201514434548A 2015-04-09 2015-04-09
US15/887,371 US20180271752A1 (en) 2012-10-09 2018-02-02 Drug delivery capsules with external intelligence

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US14/434,548 Continuation US9918904B2 (en) 2012-10-09 2013-09-23 Drug Delivery Capsules with external intelligence
PCT/US2013/061202 Continuation WO2014058605A1 (en) 2012-10-09 2013-09-23 Drug delivery capsules with external intelligence

Publications (1)

Publication Number Publication Date
US20180271752A1 true US20180271752A1 (en) 2018-09-27

Family

ID=50477779

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/434,548 Active 2033-10-10 US9918904B2 (en) 2012-10-09 2013-09-23 Drug Delivery Capsules with external intelligence
US15/887,371 Abandoned US20180271752A1 (en) 2012-10-09 2018-02-02 Drug delivery capsules with external intelligence

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US14/434,548 Active 2033-10-10 US9918904B2 (en) 2012-10-09 2013-09-23 Drug Delivery Capsules with external intelligence

Country Status (5)

Country Link
US (2) US9918904B2 (en)
EP (1) EP2906175B1 (en)
JP (1) JP6283677B2 (en)
CN (1) CN105050566B (en)
WO (1) WO2014058605A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023012306A1 (en) * 2021-08-05 2023-02-09 Thess Corporate Drug-dispensing device and system

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9937124B2 (en) 2014-09-11 2018-04-10 International Business Machines Corporation Microchip substance delivery devices having low-power electromechanical release mechanisms
US10881788B2 (en) 2015-10-30 2021-01-05 International Business Machines Corporation Delivery device including reactive material for programmable discrete delivery of a substance
US10286198B2 (en) * 2016-04-08 2019-05-14 International Business Machines Corporation Microchip medical substance delivery devices
US20170347952A1 (en) * 2016-06-06 2017-12-07 Rainbow Medical Ltd. Sensors for oral dosage forms
CN110650688B (en) * 2017-05-19 2023-12-22 恩维沃生物股份有限公司 Device and method for collecting gastrointestinal tract samples
EP3765138A1 (en) 2018-03-13 2021-01-20 Progenity, Inc. Ingestible device with relatively large payload volume
CN108338789B (en) * 2018-04-10 2023-12-19 上海臣邦医药科技股份有限公司 Intelligent capsule
US10835685B2 (en) * 2018-05-30 2020-11-17 Amgen Inc. Thermal spring release mechanism for a drug delivery device
EP3802359A4 (en) * 2018-06-11 2022-03-30 Rightis Technology, LLC Smart medication dispensing system and method
GB201900780D0 (en) * 2019-01-21 2019-03-06 Vibrant Ltd Device and method for delivering a flowable ingestible medicament into the gastrointestinal tract of a user
JP7070806B2 (en) * 2019-11-07 2022-05-18 株式会社村田製作所 Dosing detection system and medication device
EP4192568A1 (en) * 2020-08-08 2023-06-14 Novo Nordisk A/S Lumen insertable capsule

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731765A (en) * 1986-08-25 1988-03-15 Cole George W Medi minder
US4844076A (en) * 1988-08-26 1989-07-04 The Johns Hopkins University Ingestible size continuously transmitting temperature monitoring pill
US5217449A (en) * 1990-12-11 1993-06-08 Miyarisan Kabushiki Kaisha Medical capsule and apparatus for activating the same
US20090043278A1 (en) * 2005-05-27 2009-02-12 Shinsuke Tanaka Body-insertable apparatus
US20090306633A1 (en) * 2005-01-18 2009-12-10 Koninklijke Philips Electronics, N.V. Electronically controlled capsule
US20100286668A1 (en) * 2008-11-13 2010-11-11 Olympus Medical Systems Corp. Capsule medical apparatus
US20120053451A1 (en) * 2010-08-25 2012-03-01 Brown University Methods and systems for prolonged localization of drug delivery

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0713715Y2 (en) * 1990-07-06 1995-04-05 ミヤリサン株式会社 Medical capsule
US5860957A (en) * 1997-02-07 1999-01-19 Sarcos, Inc. Multipathway electronically-controlled drug delivery system
US6764446B2 (en) * 2000-10-16 2004-07-20 Remon Medical Technologies Ltd Implantable pressure sensors and methods for making and using them
US6929636B1 (en) 2000-11-08 2005-08-16 Hewlett-Packard Development Company, L.P. Internal drug dispenser capsule medical device
US8518022B2 (en) 2004-08-27 2013-08-27 Medimetrics Personalized Drug Delivery, Inc. Electronically and remotely controlled pill and system for delivering at least one medicament
US8636172B2 (en) * 2006-01-05 2014-01-28 Lawrence A. Dunn Devices, systems and methods for point-of-use medication control
RU2009101475A (en) * 2006-06-20 2010-07-27 Конинклейке Филипс Электроникс, Н.В. (Nl) ELECTRONIC CAPSULE AND METHOD FOR TREATING A GASTROINTESTINAL DISEASE
US8852172B2 (en) * 2006-11-21 2014-10-07 Medimetrics Personalized Drug Delivery Ingestible electronic capsule and in vivo drug delivery or diagnostic system
WO2008064428A1 (en) 2006-11-29 2008-06-05 Bray Kenmar Medicament dispensing device
FR2927068B1 (en) * 2008-02-05 2012-12-07 Lvmh Rech DISPENSING DEVICE FOR FLUID PRODUCT AND DISTRIBUTION METHOD
US8990018B2 (en) * 2008-03-31 2015-03-24 MEDIMETRICS Personalized Drug Delivery B.V. Method of preparing a swallowable capsule comprising a sensor
JP5188880B2 (en) * 2008-05-26 2013-04-24 オリンパスメディカルシステムズ株式会社 Capsule type medical device and method for charging capsule type medical device
JP4869312B2 (en) * 2008-10-06 2012-02-08 オリンパス株式会社 Capsule medical device
JP5263742B2 (en) * 2009-01-26 2013-08-14 国立大学法人 筑波大学 Medication confirmation system to watch the user
US8852155B2 (en) * 2009-08-12 2014-10-07 Medimetrics Personalized Drug Delivery Medicine reservoir for drug delivery device
WO2011073892A1 (en) * 2009-12-17 2011-06-23 Koninklijke Philips Electronics N.V. Swallowable capsule for monitoring a condition
WO2011114332A1 (en) * 2010-03-17 2011-09-22 Photopill Medical Ltd. Capsule phototherapy

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731765A (en) * 1986-08-25 1988-03-15 Cole George W Medi minder
US4844076A (en) * 1988-08-26 1989-07-04 The Johns Hopkins University Ingestible size continuously transmitting temperature monitoring pill
US5217449A (en) * 1990-12-11 1993-06-08 Miyarisan Kabushiki Kaisha Medical capsule and apparatus for activating the same
US20090306633A1 (en) * 2005-01-18 2009-12-10 Koninklijke Philips Electronics, N.V. Electronically controlled capsule
US20090043278A1 (en) * 2005-05-27 2009-02-12 Shinsuke Tanaka Body-insertable apparatus
US20100286668A1 (en) * 2008-11-13 2010-11-11 Olympus Medical Systems Corp. Capsule medical apparatus
US20120053451A1 (en) * 2010-08-25 2012-03-01 Brown University Methods and systems for prolonged localization of drug delivery

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023012306A1 (en) * 2021-08-05 2023-02-09 Thess Corporate Drug-dispensing device and system
FR3125962A1 (en) * 2021-08-05 2023-02-10 La Valériane Medication dispensing device and system

Also Published As

Publication number Publication date
CN105050566B (en) 2020-09-22
US20150272830A1 (en) 2015-10-01
US9918904B2 (en) 2018-03-20
WO2014058605A1 (en) 2014-04-17
EP2906175B1 (en) 2018-11-07
JP2015531298A (en) 2015-11-02
CN105050566A (en) 2015-11-11
EP2906175A4 (en) 2016-06-22
JP6283677B2 (en) 2018-02-21
EP2906175A1 (en) 2015-08-19

Similar Documents

Publication Publication Date Title
US20180271752A1 (en) Drug delivery capsules with external intelligence
JP7389158B2 (en) Device and method for detecting executable actuation operations in a medical device
TWI608851B (en) Medicament delivery device
US11197963B2 (en) Device for attachment to an injection device
CN103585021B (en) Medicament storage and dispensing apparatus and comprise the system of this device
CN106413781B (en) Recording device operated by a drug delivery device
CN106659842B (en) Recording device for a drug delivery device
US11077026B1 (en) Medication dispenser
ES2763940T3 (en) Drug administration management systems
CN101495080B (en) Drug storage and dispensing devices and systems comprising same
JP6012704B2 (en) Injection device
US10716895B2 (en) Infusion pump system and method
CN115087477A (en) Activation system for an auxiliary device attached to a medicament delivery device
CN115803073A (en) Activation and detection system for an auxiliary device attached to a medicament delivery device
GB2385845A (en) Dose dispensing apparatus

Legal Events

Date Code Title Description
AS Assignment

Owner name: PROGENITY, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:STOCO 10 GMBH;REEL/FRAME:045831/0981

Effective date: 20180517

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

AS Assignment

Owner name: MEDIMETRICS PERSONALIZED DRUG DELIVERY, B.V., NETH

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNORS:ZOU, HANS;SHIMIZU, JEFFERY A.;IORDANOV, VENTZESLAV PETROV;AND OTHERS;SIGNING DATES FROM 20170408 TO 20171020;REEL/FRAME:046395/0154

Owner name: STOCO 10 GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDIMETRICS PERSONALIZED DRUG DELIVERY, B.V.;REEL/FRAME:046395/0321

Effective date: 20170824

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION